Matthew Hall co-hosted the
March 30 episode of the Our Curious Amalgam
podcast on the topic "What Is the Competitive Drug Price? Understanding Drug
Pricing and Competition in Europe."
The pricing of pharmaceuticals, and in particular whether prices are “too
high” or “excessive”, is a contentious topic in the EU, as elsewhere. What is
“excessive” in this context and what other antitrust arguments are used in this
key sector? Paul Csiszar, Director, European Commission, DG Competition joins
Matthew Hall and others to discuss recent cases and policy directions, including
several cases based on allegations of abuse of dominance by pharmaceutical
companies. Listen to this episode to learn more about how EU
competition/antitrust law can be one part of the toolbox available to
investigate and deal with the issue of excessive pricing in pharmaceuticals.
To listen to the podcast,